Organon & Co. (OGN) Short Interest Ratio & Short Volume → Healthcare Takes A Big Step Forward With The Help Of AI (From The Bull Report) (Ad) Free OGN Stock Alerts $18.00 +0.18 (+1.01%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Organon & Co. Short Interest DataCurrent Short Volume10,930,000 sharesPrevious Short Volume10,130,000 sharesChange Vs. Previous Month+7.90%Dollar Volume Sold Short$205.48 millionShort Interest Ratio / Days to Cover4.0Last Record DateMarch 31, 2024Outstanding Shares255,640,000 sharesFloat Size255,160,000 sharesShort Percent of Float4.28%Today's Trading Volume1,484,725 sharesAverage Trading Volume2,017,332 sharesToday's Volume Vs. Average74% Short Selling Organon & Co. ? Sign up to receive the latest short interest report for Organon & Co. and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatOGN Short Interest Over TimeOGN Days to Cover Over TimeOGN Percentage of Float Shorted Over Time Ad Banyan Hill PublishingThe Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him Organon & Co. Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202410,930,000 shares $205.48 million +7.9%4.3%4 $18.80 3/15/202410,130,000 shares $185.18 million +4.3%4.0%3.4 $18.28 2/29/20249,710,000 shares $169.05 million -27.2%3.8%2.7 $17.41 2/15/202413,340,000 shares $248.39 million +8.2%5.2%3.4 $18.62 1/31/202412,330,000 shares $205.29 million -10.7%4.8%3 $16.65 1/15/202413,810,000 shares $231.32 million -27.8%5.4%3 $16.75 Get the Latest News and Ratings for OGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Organon & Co. and its competitors with MarketBeat's FREE daily newsletter. 12/31/202319,120,000 shares $275.71 million +5.8%7.5%3.4 $14.42 12/15/202318,070,000 shares $236.36 million +25.8%7.1%3.3 $13.08 11/30/202314,370,000 shares $162.67 million -1.7%5.6%2.9 $11.32 11/15/202314,620,000 shares $169.01 million +36.3%5.7%3.2 $11.56 10/31/202310,730,000 shares $158.70 million -3.3%4.2%2.5 $14.79 10/15/202311,100,000 shares $192.25 million +10.9%4.4%3 $17.32 9/30/202310,010,000 shares $173.77 million +37.9%3.9%4.1 $17.36 9/15/20237,260,000 shares $141.86 million +4.3%2.8%3.3 $19.54 8/31/20236,960,000 shares $152.84 million -0.9%2.7%3.3 $21.96 8/15/20237,020,000 shares $163.29 million +12.9%2.8%3.3 $23.26 7/31/20236,220,000 shares $136.72 million -7.2%2.4%2.7 $21.98 7/15/20236,700,000 shares $137.48 million -8.3%2.6%3.2 $20.52 6/30/20237,310,000 shares $152.12 million +5.5%2.9%3.6 $20.81 6/15/20236,930,000 shares $144.94 million -4.4%2.7%3.5 $20.92 5/31/20237,250,000 shares $140.58 million +5.1%2.9%3.5 $19.39 5/15/20236,900,000 shares $143.80 million +11.7%2.7%3.3 $20.84 4/30/20236,180,000 shares $152.21 million -8.9%2.4%3 $24.63 4/15/20236,780,000 shares $161.36 million -1.2%2.7%3.4 $23.80 3/31/20236,860,000 shares $161.35 million +7.4%2.7%3.2 $23.52 3/15/20236,390,000 shares $137.51 million -12.2%2.5%3 $21.52 2/28/20237,280,000 shares $178.29 million +31.7%2.9%3.4 $24.49 2/15/20235,530,000 shares $161.81 million +15.9%2.2%2.7 $29.26 1/31/20234,770,000 shares $143.72 million -22.6%1.9%2.5 $30.13 1/15/20236,160,000 shares $197.49 million -14.2%2.4%3 $32.06 12/30/20227,180,000 shares $200.54 million +4.5%2.8%3.6 $27.93 12/15/20226,870,000 shares $194.28 million +16.4%2.7%3.4 $28.28 11/30/20225,900,000 shares $153.52 million +7.1%2.3%3 $26.02 11/15/20225,510,000 shares $137.09 million -3.0%2.2%2.9 $24.88 10/31/20225,680,000 shares $148.70 million -1.7%2.2%3 $26.18 10/15/20225,780,000 shares $134.73 million -4.3%2.3%3.2 $23.31 9/30/20226,040,000 shares $141.34 million +1.7%2.4%3.5 $23.40 9/15/20225,940,000 shares $170.78 million +12.3%2.3%3.8 $28.75 8/31/20225,290,000 shares $150.92 million -2.6%2.1%3.5 $28.53 8/15/20225,430,000 shares $168.38 million -2.9%2.1%3.7 $31.01The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him OGN Short Interest - Frequently Asked Questions What is Organon & Co.'s current short interest? Short interest is the volume of Organon & Co. shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 10,930,000 shares of OGN short. 4.28% of Organon & Co.'s shares are currently sold short. Learn More on Organon & Co.'s current short interest. What is a good short interest ratio for Organon & Co.? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OGN shares currently have a short interest ratio of 4.0. Learn More on Organon & Co.'s short interest ratio. Which institutional investors are shorting Organon & Co.? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Organon & Co.: IMC Chicago LLC, Nomura Holdings Inc., Apollo Management Holdings L.P., Capstone Investment Advisors LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Organon & Co.? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.28% of Organon & Co.'s floating shares are currently sold short. Is Organon & Co.'s short interest increasing or decreasing? Organon & Co. saw a increase in short interest in March. As of March 31st, there was short interest totaling 10,930,000 shares, an increase of 7.9% from the previous total of 10,130,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Organon & Co.'s float size? Organon & Co. currently has issued a total of 255,638,000 shares. Some of Organon & Co.'s outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Organon & Co. currently has a public float of 255,160,000 shares. How does Organon & Co.'s short interest compare to its competitors? 4.28% of Organon & Co.'s shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Organon & Co.: Madrigal Pharmaceuticals, Inc. (16.88%), BridgeBio Pharma, Inc. (10.29%), Alpine Immune Sciences, Inc. (8.05%), Nuvalent, Inc. (20.22%), Perrigo Company plc (2.85%), Alkermes plc (8.48%), Insmed Incorporated (6.09%), Blueprint Medicines Co. (7.14%), CymaBay Therapeutics, Inc. (5.10%), Biohaven Ltd. (10.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Organon & Co. stock? Short selling OGN is an investing strategy that aims to generate trading profit from Organon & Co. as its price is falling. OGN shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Organon & Co.? A short squeeze for Organon & Co. occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OGN, which in turn drives the price of the stock up even further. How often is Organon & Co.'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OGN, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: Madrigal Pharmaceuticals Short Interest BridgeBio Pharma Short Interest Alpine Immune Sciences Short Interest Nuvalent Short Interest Perrigo Short Interest Alkermes Short Interest Insmed Short Interest Blueprint Medicines Short Interest CymaBay Therapeutics Short Interest Biohaven Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:OGN) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative